These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21155811)

  • 21. Surface tension and wettability in transdermal delivery: a study on the in-vitro permeation of haloperidol with cyclodextrin across human epidermis.
    Azarbayjani AF; Lin H; Yap CW; Chan YW; Chan SY
    J Pharm Pharmacol; 2010 Jun; 62(6):770-8. PubMed ID: 20636865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.
    Nakate T; Yoshida H; Ohike A; Tokunaga Y; Ibuki R; Kawashima Y
    Eur J Pharm Biopharm; 2003 Mar; 55(2):147-54. PubMed ID: 12637090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
    Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
    Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
    Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
    Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced oral delivery of antimony from meglumine antimoniate/beta-cyclodextrin nanoassemblies.
    Frézard F; Martins PS; Bahia AP; Le Moyec L; de Melo AL; Pimenta AM; Salerno M; da Silva JB; Demicheli C
    Int J Pharm; 2008 Jan; 347(1-2):102-8. PubMed ID: 17656054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
    Govindarajan R; Nagarsenker MS
    J Pharm Pharmacol; 2004 Jun; 56(6):725-33. PubMed ID: 15231037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
    Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
    Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
    Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
    Smith JS; Macrae RJ; Snowden MJ
    Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lumichrome complexation by cyclodextrins: influence of pharmaceutical excipients.
    Lilletvedt M; Kristensen S; Tønnesen HH
    Pharmazie; 2010 Dec; 65(12):871-6. PubMed ID: 21284255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
    Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
    J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.